US FDA’s ALS Science Strategy Includes Near-Term Rare Neurodegenerative Disease Task Force

 
• By Ramsey Baghdadi
Neurodegenerative disease
The FDA's plan is aimed at accelerating product development for the treatment of rare neurodegenerative diseases. • Source: Shutterstock

More from Approval Standards

More from Pathways & Standards